Company Analysis

Sarepta Therapeutics, Inc. (SRPT)

Nasdaq: SRPT · Pharmaceutical Preparations · Cambridge, MA · filing with the SEC since 1997
Grade6.2
◀ Past 8.0● Present 5.6▶ Future 5.0
1 est.

Who runs Sarepta Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Severino Michael
Chief Executive Officer. First filing Jul 2026, latest Jul 29, 2026, 0 filings in all.
Officers reporting now
7
of 15 people with a filing in the last fifteen months
Directors reporting now
8
35 people on the record since 2007
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Rodino-Klapac LouisePresident, R&D and Tech OpsDec 2020Sep 8, 2026none
Wong Ryan Ho-YanChief Financial OfficerJul 2025Sep 8, 2026none
Estepan Ian MichaelChief Operating OfficerDec 2020Sep 8, 20261 · $300,000
Rothfuss CristinEVP, General CounselNov 2024Sep 8, 2026none
Severino MichaelChief Executive OfficerJul 2026Jul 29, 2026none
Ingram Douglas SChief Executive OfficerJun 2017Dec 9, 2025none
Arif BilalChief Tech Ops OfficerJan 2023Aug 6, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Barry RicharddirectorJun 2015Jun 5, 2026none
Behrens M KathleendirectorApr 2009Jun 5, 2026none
Boor Kathryn JeandirectorJun 2022Jun 5, 2026none
Chambers Michael AndrewdirectorJun 2022Jun 5, 2026none
Connelly Deirdre PdirectorSep 2024Jun 5, 2026none
Mayo StephendirectorNov 2021Jun 5, 20261 · $100,000
Nicaise ClaudedirectorJun 2015Jun 5, 2026none
Wigzell Hans Lennart RudolfdirectorJun 2010Jun 5, 2026none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SRPT · research, not advice